Navigation Links
Practical Diabetology Highlights Advanced Lipid Testing for Type 2 Diabetes Patients
Date:9/17/2010

BIRMINGHAM, Ala., Sept. 17 /PRNewswire/ -- Detailed cholesterol testing for Type 2 diabetes patients is the focus of a newly published article by Atherotech Diagnostics Lab Chief Medical Officer Michael E. Cobble, M.D. "Advanced Lipid Testing" appears in the September/October 2010 quarterly issue of Practical Diabetology.

(Photo:  http://photos.prnewswire.com/prnh/20091228/LA30526)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20091228/LA30526)

The article discusses the clinical advantages of advanced cholesterol testing in reducing cardiovascular disease (CVD) risk in patients with Type 2 diabetes and details several currently available advanced lipid tests, including the VAP® Cholesterol Test from Atherotech. Cobble also explores which patients are appropriate to test and how to apply advanced lipid testing results.

Advanced lipid testing is affordable, widely available and may provide valuable information in the treatment and management of people living with Type 2 diabetes, explained Cobble, who is also a director, researcher and clinician at Canyons Medical Center in Sandy, Utah.

"We know that aggressive management of multiple cardiovascular disease risks in diabetes mellitus patients has proven beneficial," Cobble said. "But in order to properly treat these patients, we first must identify them and effectively assess their risk. This is achieved through advanced lipid profiles."

Diabetes is a high-risk CVD condition that affects more than 24 million Americans, and patients with Type 2 diabetes are considered high risk due to traditional CVD risk factors and residual lipid risk factors, all of which can be determined through detailed lipoprotein assays such as the VAP Test.

"Standard lipid tests miss more than half of all at-risk patients, and may actually underestimate the number of lipoprotein particles that can lead to atherosclerotic plaques," Cobble said. "When it comes to diabetic patients, the standard test simply doesn't give us enough data to make the best decisions for our patients."

Advanced lipid tests provide a more sophisticated measurement of LDL, HDL, VLDL, non-HDL and other lipid subcomponents. The Vertical Auto Profile (VAP), for example, reports the relative distribution of cholesterol content of all lipoproteins and subfractions — 22 components of blood cholesterol to be exact — at no additional cost.

The VAP Test includes Lp(a) and reports all three lipoprotein parameters — LDL, non-HDL and apoB — considered necessary by the expert consensus guidelines issued by the American Diabetes Association and American College of Cardiology. Unlike the standard lipid profile, the VAP Test directly measures LDL and is therefore unaffected by triglycerides, allowing the test to be performed in non-fasting patients. The VAP Test reports all lipoproteins and apolipoproteins, including apoA1 and the apoB/apoA1 ratio, and it can identify triglyceride remnant markers for Metabolic Syndrome, a precursor and coexistor to diabetes.

Practical Diabetology provides practical information to physicians to enhance the care and treatment of diabetes patients. It is published quarterly and available by subscription by calling 212-989-0200. The VAP Test is available nationwide and widely covered by insurance. For more information call 877-901-8510  or visit www.atherotech.com. Atherotech Diagnostics Lab is on Twitter, @Atherotech, and also on Facebook at www.Facebook.com/Atherotech.

About Atherotech Diagnostics Lab

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.atherotech.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Michael Cobble, M.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=94439


'/>"/>
SOURCE Atherotech Diagnostics Lab
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
2. Best Practices, LLC Research Highlights Critical Role of Medical Marketing in New Product Launch Success
3. Wise Sky Highlights Their Disappointment at Emergents Decision Not to Enter the China Market
4. Homeopathic Pharmacists Association Highlights the Extraordinary Safety Record of Homeopathic Medicines
5. Data Published in Proceedings of National Academy of Sciences Highlights Potential of Micromets BiTE Antibody Platform
6. Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
7. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
8. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
9. DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call
10. LightLab Highlights OCT Market Leadership at the Society for Cardiovascular Angiography and Interventions
11. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... Datascope Corp. is voluntarily performing a worldwide field correction of certain ... failure code.     ... PART NUMBER ... 0998-UC-0446HXX; 0998-UC-0479HXX 0998-00-3013-XX;  0998-UC-3013-XX ... This field correction also applies to any ...
(Date:6/14/2017)... 14, 2017 The Bio Supply Management Alliance ... of Fremont and the Biomedical Manufacturing Network ... in California by providing a ... and fostering workforce development. The primary focus of this ... start-ups, as well as small and mid-sized biomedical companies. ...
(Date:6/12/2017)... June 12, 2017 Kineta, Inc., a biotechnology company ... Kineta Vice President of R&D and Head of Virology ... Pandemic Preparedness for the Northwest and Beyond meeting sponsored ... June 14, 2017 from 8:30-10:30 AM PDT at the Agora ... Dr. Bedard will be joined by other leaders ...
Breaking Medicine Technology:
(Date:6/28/2017)... Church, VA (PRWEB) , ... June 28, 2017 , ... ... http://www.fdanews.com/fdaeumdregs      , No matter on which side of the Atlantic devicemakers ... medical device regulations they have to follow. , In addition to the full text ...
(Date:6/28/2017)... IL (PRWEB) , ... June 28, 2017 , ... David B. Sosin, a ... Park, Illinois, took over the post of 2nd Vice President for the Illinois State ... was installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election and ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. ... a two year study conducted by the University of Saskatchewan in partnership with ... remediating potash brine-impacted groundwater. As a part of the study, batch adsorption experiments ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with ... lodgings for families with children receiving treatment in nearby hospitals. , Ronald McDonald ...
(Date:6/27/2017)... ... ... Harbour , a DAO (decentralized autonomous organization) that harnesses the wisdom ... technical specifications . , 2017 has seen an explosion of token launches by ... offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, said, ...
Breaking Medicine News(10 mins):